Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,842.40
(
0.45%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
97.03
(
1.86%
)
Bitcoin
67,140.25
(
0.68%
)
News Focus
News Focus
Post# of 828961
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

NotSure2

Send PM Follow Ignore
Followers 7
Posts 820
Boards Moderated 0
Alias Born 12/23/2021

NotSure2

Re: hyperopia post# 685240

Monday, 04/15/2024 11:34:53 AM

Monday, April 15, 2024 11:34:53 AM

Post# of 828961
Here is some info that might help you out in your analysis:

https://www.nice.org.uk/guidance/indevelopment/gid-ta10143/documents

Click on: "NICE's response to comment of the draft scope and provisional matrix"

Read the first row, to the right:

Comment noted. NICE
aims to publish
guidance on cancer
drugs within 90 days of
marketing authorisation.
Any requirements for
potential delays will be
taken into account as
appropriate.

Pretty much as you said it, a few months after approval ish for NICE timeline.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News